BOT
Click for more information
0.67% 37.8¢ botanix pharmaceuticals ltd

Ann: Dermatology Asset Acquired to Accelerate Path to Revenue, page-23

  1. makinbank
    60 Posts.
    lightbulb Created with Sketch. 5
    clock Created with Sketch.
    04/05/22
    11:39
    Post #: 61194651
    This company has always been flagged as a pot stock wrongly, yes they use synthetic CBD but they are a pharma company focussing on derma - as proven with this purchase and not confining themselves and their products to just contain synth CBD
    Last edited by makinbank: 04/05/22
    BOT Price at posting: 9.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.8¢ 		Change
0.003(0.67%) 		Mkt cap ! $559.1M
Open High Low Value Volume
37.0¢ 38.0¢ 35.5¢ $3.182M 8.699M

Buyers (Bids)

No. Vol. Price($)
7 145132 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 534353 16
View Market Depth
Last trade - 13.04pm 25/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.